Williams S A, Rayman G, Tooke J E
Department of Physiology, Charing Cross and Westminster Medical School, London, England.
Eur J Clin Pharmacol. 1989;37(4):333-5. doi: 10.1007/BF00558495.
We studied the incidence of oedema 2 weeks following initiation of nifedipine therapy for hypertension in a group of 10 diabetic subjects, and also measured skin blood flow (SBF) with a laser Doppler flowmeter, before and after lowering the foot. SBF with the foot horizontal increased after nifedipine from 0.31 V (arbitrary units of flow) to 0.51 V (NS). The postural fall in blood flow in dependency was significantly attenuated by nifedipine from 64.4 to 24.0%. Five patients developed ankle oedema. Results were similar in a small group of non-diabetic subjects starting nifedipine. The attenuation of reflex postural vasoconstriction is therefore likely to contribute to development of the oedema associated with starting nifedipine therapy, which should be monitored carefully in diabetic patients.
我们研究了一组10名糖尿病患者在开始使用硝苯地平治疗高血压2周后水肿的发生率,并且在放下足部前后,用激光多普勒血流仪测量了皮肤血流量(SBF)。足部水平放置时,硝苯地平治疗后SBF从0.31V(任意血流单位)增加到0.51V(无统计学意义)。硝苯地平显著减轻了因体位改变导致的血流下降,从64.4%降至24.0%。5名患者出现了脚踝水肿。在一小群开始使用硝苯地平的非糖尿病患者中,结果相似。因此,反射性体位性血管收缩的减弱可能导致了与开始硝苯地平治疗相关的水肿的发生,糖尿病患者应密切监测。